Association of previous cardiac surgery with outcomes in left ventricular assist device patients.


Journal

Interactive cardiovascular and thoracic surgery
ISSN: 1569-9285
Titre abrégé: Interact Cardiovasc Thorac Surg
Pays: England
ID NLM: 101158399

Informations de publication

Date de publication:
01 07 2020
Historique:
received: 14 07 2019
revised: 05 02 2020
accepted: 21 02 2020
pubmed: 6 4 2020
medline: 2 2 2021
entrez: 6 4 2020
Statut: ppublish

Résumé

History of prior cardiac surgery has traditionally been considered a risk factor for subsequent cardiac procedures. The aim of this study was to investigate the outcomes of patients implanted with a left ventricular assist device via redo sternotomy. Prospectively collected data were reviewed for all patients implanted with a continuous-flow left ventricular assist device at a single institution from December 2006 through June 2018. Patients were separated into 2 cohorts: those with a history of prior cardiac surgery (redo sternotomy) and those undergoing primary sternotomy at the time of left ventricular assist device implantation. The primary outcome was overall survival. Of the 321 patients included in the study, 77 (24%) were implanted via redo sternotomy and 244 (76%) via primary sternotomy. The redo sternotomy cohort was generally older (59 ± 10 vs 57 ± 12 years, P = 0.050) and had a higher incidence of ischaemic disease (70% vs 49%, P = 0.002). The Kaplan-Meier survival analysis demonstrated that overall survival was not significantly different between the redo sternotomy and primary sternotomy groups (6-month survival: 86% vs 92%; 5-year survival: 53% vs 51%; log-rank P = 0.590 for overall difference during follow-up). The propensity score analysis consistently showed that redo sternotomy was not significantly associated with mortality risk (hazard ratio 1.19, 95% confidence interval 0.73-1.93; P = 0.488). Redo sternotomy patients were more likely to require rehospitalization during their first year postoperatively (P = 0.020) and spent less time out of the hospital during the first year (P = 0.046). The redo sternotomy cohort represents a more technically challenging patient population, but overall survival similar to that of primary sternotomy patients can be achieved.

Identifiants

pubmed: 32248242
pii: 5816051
doi: 10.1093/icvts/ivaa055
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1-8

Informations de copyright

© The Author(s) 2020. Published by Oxford University Press on behalf of the European Association for Cardio-Thoracic Surgery. All rights reserved.

Auteurs

Brian C Ayers (BC)

Division of Cardiac Surgery, Department of Surgery, University of Rochester Medical Center, Rochester, NY, USA.

Katherine Wood (K)

Division of Cardiac Surgery, Department of Surgery, University of Rochester Medical Center, Rochester, NY, USA.

Scott McNitt (S)

Division of Cardiology, Cardiovascular Research Center, University of Rochester Medical Center, Rochester, NY, USA.

Ilan Goldenberg (I)

Division of Cardiology, Cardiovascular Research Center, University of Rochester Medical Center, Rochester, NY, USA.

Leway Chen (L)

Division of Cardiology, Department of Medicine, University of Rochester Medical Center, Rochester, NY, USA.

Jeffrey Alexis (J)

Division of Cardiology, Department of Medicine, University of Rochester Medical Center, Rochester, NY, USA.

Himabindu Vidula (H)

Division of Cardiology, Department of Medicine, University of Rochester Medical Center, Rochester, NY, USA.

Sabu Thomas (S)

Division of Cardiology, Department of Medicine, University of Rochester Medical Center, Rochester, NY, USA.

Eugene Storozynsky (E)

Division of Cardiology, Department of Medicine, University of Rochester Medical Center, Rochester, NY, USA.

Bryan Barrus (B)

Division of Cardiac Surgery, Department of Surgery, University of Rochester Medical Center, Rochester, NY, USA.

Sunil Prasad (S)

Division of Cardiac Surgery, Department of Surgery, University of Rochester Medical Center, Rochester, NY, USA.

Igor Gosev (I)

Division of Cardiac Surgery, Department of Surgery, University of Rochester Medical Center, Rochester, NY, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH